ProShare Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.1K Sell
52,766
-87,892
-62% -$112K ﹤0.01% 1803
2026
Q1
$160K Sell
140,658
-15,696
-10% -$19.3K ﹤0.01% 1636
2025
Q4
$197K Buy
156,354
+85,985
+122% +$120K ﹤0.01% 1728
2025
Q3
$109K Sell
70,369
-3,815
-5% -$5.24K ﹤0.01% 1829
2025
Q2
$97.9K Buy
74,184
+5,139
+7% +$7.03K ﹤0.01% 1883
2025
Q1
$115K Sell
69,045
-22,685
-25% -$37.4K ﹤0.01% 1806
2024
Q4
$135K Buy
91,730
+30,182
+49% +$46.1K ﹤0.01% 2004
2024
Q3
$91.7K Buy
61,548
+7,521
+14% +$11.2K ﹤0.01% 1896
2024
Q2
$67.5K Sell
54,027
-18,443
-25% -$23.9K ﹤0.01% 1714
2024
Q1
$87K Buy
72,470
+5,704
+9% +$5.71K ﹤0.01% 1843
2023
Q4
$101K Buy
66,766
+14,365
+27% +$20.8K ﹤0.01% 1779
2023
Q3
$83.8K Sell
52,401
-60
-0.1% -$109 ﹤0.01% 1663
2023
Q2
$114K Buy
52,461
+4,942
+10% +$7.73K ﹤0.01% 1676
2023
Q1
$69.4K Sell
47,519
-4,431
-9% -$5.7K ﹤0.01% 1641
2022
Q4
$64.9K Buy
51,950
+7,444
+17% +$11.7K ﹤0.01% 1709
2022
Q3
$84K Sell
44,506
-848
-2% -$2K ﹤0.01% 1593
2022
Q2
$115K Sell
45,354
-29,569
-39% -$86.2K ﹤0.01% 1590
2022
Q1
$257K Sell
74,923
-12,374
-14% -$43.7K ﹤0.01% 1744
2021
Q4
$420K Buy
87,297
+36,089
+70% +$146K ﹤0.01% 1574
2021
Q3
$187K Sell
51,208
-171,192
-77% -$637K ﹤0.01% 1809
2021
Q2
$901K Buy
222,400
+23,393
+12% +$91.7K ﹤0.01% 1102
2021
Q1
$854K Buy
199,007
+7,498
+4% +$35.8K ﹤0.01% 1087
2020
Q4
$756K Buy
191,509
+34,808
+22% +$145K ﹤0.01% 1015
2020
Q3
$578K Sell
156,701
-4,387
-3% -$18.5K ﹤0.01% 888
2020
Q2
$549K Buy
161,088
+46,863
+41% +$105K ﹤0.01% 908
2020
Q1
$153K Sell
114,225
-81,980
-42% -$128K ﹤0.01% 1036
2019
Q4
$288K Sell
196,205
-11,053
-5% -$18.5K ﹤0.01% 1360
2019
Q3
$433K Sell
207,258
-16,390
-7% -$33.5K ﹤0.01% 1030
2019
Q2
$546K Sell
223,648
-25,848
-10% -$56.4K ﹤0.01% 982
2019
Q1
$651K Buy
249,496
+15,021
+6% +$45.5K ﹤0.01% 930
2018
Q4
$706K Sell
234,475
-45,988
-16% -$156K ﹤0.01% 816
2018
Q3
$970K Sell
280,463
-5,691
-2% -$30.2K 0.01% 832
2018
Q2
$1.34M Buy
286,154
+18,184
+7% +$69K 0.01% 730
2018
Q1
$849K Sell
267,970
-43,216
-14% -$174K 0.01% 893
2017
Q4
$1.52M Sell
311,186
-12,560
-4% -$72.9K 0.01% 691
2017
Q3
$2.22M Buy
323,746
+28,997
+10% +$183K 0.02% 536
2017
Q2
$1.94M Sell
294,749
-10,536
-3% -$73.9K 0.02% 567
2017
Q1
$2.44M Sell
305,285
-68,238
-18% -$575K 0.03% 503
2016
Q4
$3.47M Buy
+373,523
New +$3.86M 0.04% 404
2016
Q3
Sell
-10,655
Closed -$100K 1501
2016
Q2
$100K Buy
+10,655
New +$108K ﹤0.01% 1523
2016
Q1
Sell
-11,935
Closed -$120K 1637
2015
Q4
$120K Buy
11,935
+274
+2% +$2.75K ﹤0.01% 1621
2015
Q3
$98K Buy
+11,661
New +$154K ﹤0.01% 1387
2015
Q2
Sell
-38,073
Closed -$539K 1738
2015
Q1
$539K Sell
38,073
-4,242
-10% -$55.2K 0.01% 1137
2014
Q4
$423K Sell
42,315
-35,969
-46% -$308K ﹤0.01% 1296
2014
Q3
$666K Sell
78,284
-17,747
-18% -$156K 0.01% 1239
2014
Q2
$849K Sell
96,031
-95,116
-50% -$831K 0.01% 1248
2014
Q1
$1.78M Buy
191,147
+176,927
+1,244% +$1.55M 0.02% 836
2013
Q4
$120K Sell
14,220
-105,045
-88% -$1.06M ﹤0.01% 1297
2013
Q3
$1.05M Buy
119,265
+49,714
+71% +$399K 0.02% 840
2013
Q2
$494K Buy
+69,551
New +$480K 0.01% 1335

Other funds holding OPK

ProShare Advisors's OPK Position: Q2 2026 in Review

ProShare Advisors reduced its Opko Health (OPK) stake by 62% in Q2 2026, selling an estimated $112K and leaving 52,766 shares worth $79.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

ProShare Advisors first reported a position in OPK in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.47M in Q4 2016. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • ProShare Advisors held 52,766 shares of Opko Health worth $79.1K as of Q2 2026.
  • ProShare Advisors sold 87,892 Opko Health shares in Q2 2026, an estimated $112K.
  • Opko Health made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1803 holding.
  • ProShare Advisors first reported a position in Opko Health in Q2 2013 and has held it in 50 quarters since.
  • ProShare Advisors's Opko Health position peaked at $3.47M in Q4 2016.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.